clonidine for ADHD
Selected indexed studies
- Evidence-based pharmacological treatment options for ADHD in children and adolescents. (Pharmacol Ther, 2022) [PMID:34174276]
- Current Pharmacological Treatments for ADHD. (Curr Top Behav Neurosci, 2022) [PMID:35507282]
- Nonstimulant Treatments for ADHD. (Child Adolesc Psychiatr Clin N Am, 2022) [PMID:35697393]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Current Pharmacological Treatments for ADHD. (2022) pubmed
- Nonstimulant Treatments for ADHD. (2022) pubmed
- Drugs for ADHD. (2025) pubmed
- Evidence-based pharmacological treatment options for ADHD in children and adolescents. (2022) pubmed
- Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. (2018) pubmed
- Nonstimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults: Systematic Review and Meta-analysis. (2023) pubmed
- Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. (2018) pubmed
- Drugs for ADHD. (2020) pubmed
- Psychopharmacology of Attention-Deficit Hyperactivity Disorder: Effects and Side Effects. (2016) pubmed
- Clonidine oral suspension (Onyda XR) for ADHD. (2024) pubmed